. I have today made my own enquiries with AstraZeneca directly on 1-877-240-9479 and they (Camellia) have confirmed that this trial is not yet recruiting and she also confirmed that the day recruitment starts the status on the website will be updated. My understanding is this condition has not been met however each KMP has received 191,152 rights for this alongside other staff whose allocation will no doubt vary according to the capacity of their employment. We would like to show you a description here but the site won’t allow us. This is a charting thread for those interested in the movements of the SPL SP. StarPharma Holdings Ltd. Follow your favourite stocks, view charts, track. . HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. Attached link highlights some of the complexities involved more broadly. Virtual investor presentation Tomorrow night Starpharma will be Participating in a virtual investorpresentation on the OTC website for those that are. Model # 407730 Store SKU # 1000846365. 0¢ Sentiment: None Disclosure: Not HeldHi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Latest Posts. My last 350 posts take me back over two years and cover about twenty different stocks. Target our investor community with our suite of Hotcopper Advertising opportunities. 72. Dr. Above $20m revenue, SPL rakes in zero R&D tax refunds until revenue becomes high enough for SPL to actually make a profit. The upper and lower pennant lines will intersect in three months. ASX - By Stock. ASX - Day Trading. ASX - By Stock. 48. Hope that SPL starts to deliver on its promises. News: SPO Spotless Group To Be Removed From Official List Of ASX Ltd At Close Of Trading On 30 Aug. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. ROFL. SPL. When a board member uses rheir own hard earned cash and buys $350,000 worth of shares. Just to refresh people's memory I thought this summed by the exact situation with the TGA and Starpharm STARPHARMA’S COVID-KILLER NEEDS ACTION NOT. and I dont like what I am seeing. , page-2. Commodities. Add SPL (ASX) to my watchlist (20min delay). NEW YORK TRANSN DEV CORP SPL FAC REV 4. but hey don't take my word for it, see for yourself in the official SPL ASX announcement dated 17th April 2023 You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. Release Date: 27/06/22 09:19; Summary: SPL signs expanded DEP research agreement with US Biopharma; Price Sensitive: Yes; Download Document 194. 37pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on WHISPIR LIMITED. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. Overview. 50 At this stage in the game, I would not accept anything under $5 (fact)Btw if Starpharma do receive an upfront milestone of $300 million for Dep Docetaxel, Dep Cabazitaxel and Dep Irinotecan license, I believe a special dividend will be paid out to all. DISCOVER THE BATTERY METALS REVOLUTION. 43pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Market Cap $58. 0¢. . 50 or. Created with Sketch. Let's not forget that this happened due to the poor performance of management that contributed to SPL getting the boot from. Join the HotCopper ASX share market forum today for free. 70 Sentiment: Sell Disclosure: HeldNot only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and. Created with Sketch. However, just a word of caution before the usual pumping starts by the usual suspects. 57. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Latest Posts. Check out the spin on this promo---One ASX company Set to Revolutionise the $112 BILLION Cancer-Drug MarketBy: Adam SurpliceIndustry experts expect that. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. If SPL come out with more data and partners or a potential pathway to sales, great, i will change my view and the price will likely spike. It seems long-suffering retail. Volume. com Investors: Chas Cook — 336-436-5076 Investor@Labcorp. 15667. 6 MILLION HY LOSS FROM CONTINUING OPERATIONS. . Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. ASX - Day Trading. 0¢ Sentiment: Hold Disclosure: Held Share Hi Folks Time to revisit the SPL Weekly chart. 45K. Deliver ZERO dividends, a NEGATIVE capital return and depressed share price to shareholders over a 17 year period. 409118. ASX - By Stock. I find it alarming the number of column inches in the resolution explanatory notes, extolling their experiences prior to spl, when not one of them has any achievements in the advancement of spl listed. 12. 1dB. Share Step 1. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). 0¢ STARPHARMA HOLDINGS LIMITED - Corporate Spotlight . Application for quotation of securities - SPL. Last updated 15. A new DFS upgrade has expanded operation capacity on-site the project from 15 gigawatt hour’s worth of battery production to 120GWh. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial. ASX - Day Trading. It would be nice to have SPL make an announcement to the market to clear up the uncertainty around the many market sensitive announcements made that seem to have just faded into the background with no update as to whether they are progressing or if they have ceased. I think SPL are very worried on what a potential class action could implicate. Created with Sketch. 63M. Interesting write-up. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. 22/9/2000 CSL $11. I know that Company's have to concentrate on the task at hand but an awareness of the World Economy is important. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 615, today the share price rose by 0. 0. ASX - Short Term Trading. See All Discussions. New Zealand Dollar. 0 Created with. Safety, tolerability and side effects appear to be superior to all the base drugs, and that should be enough to sell the licenses. DYOR Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. Advertise on HotCopper. That won’t be a shock to. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. In March 2020 the SPL share price dropped to a low of 0. ASX - Day TradingSo the share price of SPL rose up to a high of $2. However, the interim results from ongoing Phase One NCT04865419 (the most advanced trial) was a little underwhelming IMO. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 74. Comments. 26. Charts. While the chart is not good there is a glimmer hope maybe emerging. Become the CEO of Starpharma Step 2. Forums. The ASX is trying to crack down on many companies. As we know from the latest SPL update, it’s still ongoing… In my opinion, she is the WORST value CEO on the ASX. ASX - General. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. Share Interesting and positive early pre-clinical results. I visited their offices in Melbourne near the Alfred a few times and thought they were on to some pretty neat tech. Created with Sketch. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . And somebody must be buying all the shares that are being sold. I was hoping for. 6. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Created with Sketch. Energy. 5. Created with Sketch. 53pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. 37. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. SPL. 40. 5¢. 37 Sentiment: Buy Disclosure: Held. Target our investor community with our suite of. Become a member of Australia's largest investment discussion forum. . granted mgt haven’t covered themselves in glory as yet but the selldown has been nothing short of astonishing. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial Review About this app. All that seems to happen is that new verses are sometimes added. Latest Posts. Share I sometimes wonder if they actually work at Starpharma. 5¢. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. The results will be good but will they be good enough for SPL to be able to do the deals. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Join the HotCopper ASX share market forum today for free. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. International Markets. StarPharma Holdings Ltd. 0. For a small cap like spl where the revenue stream created would be very large in the context of our current. Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). ASX - By Stock. 24am 31/10/2023 ? Share Prices & Charts for STARPHARMA HOLDINGS LIMITED. Hey, "smart", I concur with your message. Hi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. $0. ASX - By Stock. Created with Sketch. 4¢. More. Created with Sketch. distraction achieved. ASX - Day TradingDoes Spl deserve to be seven times less in mkt cap to another biotech that has one phase 2 product spl potentially 3 and commercialisation deal with astra zeneca and collaboration deals with Merck and Genentech. . Disowned him really. Toll free: 1-877-388-4440 Email: CTBTaxQuestions@gov. Last updated 15. ASX - Short Term Trading. I remember seeing a post on SPL had 41000 views. Your missing the signals guys/gals looking too much at Viraleze, other products, CEO, BOD etc, read the signals my friend's there is a major DEP Move in. . Created with Sketch. In SPL's case there is clearly another. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. . Views. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Charts. Last updated 10. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer model (BT474). SPL. ASX - Short Term Trading. . All along, SPL have said that they may sell off this entire arm of the business, or in fact once the Dep oncology advances further, perhsps split SPL into different businesses on the asx or to be sold off as completely separate businesses. Eight (8) contributors to the HC SPL thread made price predictions (thank. As of 2015, HotCopper was in the top 170 websites in Australia and was. ASX - Day TradingShare Can you point out what you believe are their failings with respect to regulatory filings for a "medical device"? Also do you consider that government and regulatory sentiment may have had an impact on consumer demand and any advertising plan - its clear that Governments are still fixated on Vaccination to the disregard of any. 8985. And that is my opinion too but about SPL. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. 68. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . CEO knows it is all going. 0¢. ca/pst. The digital display offers a 0. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. ASX - Day TradingIn my opinion, most rational people would have to concede/agree that Starpharma’s three SPL7013 commercialised products (Fleurstat, condoms and Viraleze) have been commercial flops so far. . $0. Some days I wondered if I'd see 91c again, but when the Vivagel phase 3 announcement came out I loaded up big time. DJPIN. The goal of the partnership. and as I said I met @Domesticgod there, which was a pleasure. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. Taking Cols scenario for a sting like buyout if the buyout price is higher than the highest price the company has reached there is no avenue for complaint. Latest Posts. Created with Sketch. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. , page-4. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Furthermore the shameful and disappointing thing is that some pumpers on this forum were encouraging newbies (even when the SP hit its $2. Some links within this article worth a scan too. SPL could announce tomorrow that DEP doesn’t work and they’ll still find a way to spin it positively. Each to their own. Last updated 15. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. Latest Posts. “Who in at SPL made these commitments on timelines?” ~ @Joelsmith2452 CEO Jackie Fairley first told shareholders that the current Phase 2 DEP-Docetaxel trial would be complete by the end of CY2018. To be fair the ASX has made tries on 3 recent contracts to squeeze information from SPL when didn’t want to disclose how immaterial the contracts is. 72. I just hope that Starpharma shareholders sit up and notice at how the leaders of our company (the Chairman and CEO). Today it closes up 5% on the high of the bar and all we here. . 70. Created with Sketch. Can anybody load up the most recent Bell Potter Analysis on SPL? I am unable to source it thanks. TSASC INC N Y 5% 0. ASX - By Stock. Perhaps they will today tomorrow. Add SPL (ASX) to my watchlist (20min delay). Notice to Sellers of Vapour Products – PST Rate Increase to 20% Page 3 of 3 Need more info? Online: gov. No change of interest notification received. The borders are now open Look forward to a positive outcome with new partnership agreements permeating from our team networking at ASCO. When it goes to 62 cents, and it will as it's 1 cent away, it will be a 282-week low, or 5 years 8 months since it's been at that level, that's a lot of holders if not all on them in the red. I have just sent. I look forward to holding SPL at task - this will be the third time I have been involved in pushing for a shareholder class action, which I can say on the previous two occasions resulted in a more communicative and transparent company, which ultimately is what I. Share Great ad I think it will boom in Hong Kong under the Banitore Manning name, despite what the naysayers say Banitore have a big presence in China their manufacturing of health products is also in China I would imagine they have significant pull in China and other regions, In my opinion Viraleze is set to be a huge world product in tome. . ASX - General. . SPL is tanking, HQ are overpromising and under delivering. 1 Introduction. I constantly question why I continue to subject myself to the ongoing. NEVER - there should be an official corruption enquiry considering the Gov Funding and R&D reimbursements recieved by SPL and what actually was achieved and why they haven't been succesful - there's US companies flogging Povidine Iodine nasal spray and throat sprays left right and centre. Forums. Interesting write-up. The Company is. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. Created with Sketch. Volume. Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. Forums. 0¢. ASX - General. 00. Join the HotCopper ASX share market forum today for free. Advertise on HotCopper. and the Government Medical Research Fund which provided $1mil to SPL to aid in developing Viraleze. Latest Posts. Latest Posts. Sorry a Faulty Towers and BMC tragic and possibly a SPL one as well . Last updated 15. 8¢. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). ,), Okamoto, LifeStyles, Aspen and Mundipharma. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. 16. Forums. ASX - General. 0 Great. Dec 14 (Reuters) - Starpharma Holdings Ltd (SPL) : VIRALEZE NASAL SPRAY REGISTERED IN INDONESIA PROGRESSING DISCUSSIONS WITH POTENTIAL DISTRIBUTION. Created with Sketch. Last updated 15. Charts. ASX - Day TradingHi guys, I have held SPL shares for over 9 years and I will continue to hold. We had a Dec 2021 DCB of around the FIB 23. Target our investor community with our suite of Hotcopper Advertising. ASX - By Stock. A halleluljah announcement just days before the AGM would imo be proof that investors in SPL have for years been treated like mugs. SPL have put a lot of time and energy into Docetaxel and Cabazitaxel over many years but it is Irinotecan that seems to be wining the race, probably benefiting from the accrued knowledge from the Doc and Cab trials. . . Join the HotCopper ASX share market forum today for free. Latest Posts. I've been a SPL shareholder since Nov 2015 when I bought a small parcel at 91c. No China virus, no Flu, no colds. 0¢ Sentiment: None Disclosure: Held LikesThe CEO seemed to exude a certain excitement in her interview with Alan Kholher have never seen her like that it was bubbling underneath every time she spoke about Viralease. Created with Sketch. 0000. There appears to be a different behavioural feel about. Forums. Hope that SPL starts to deliver on its promises. SPL scientists will no doubt be working on this right now. 9¢. Created with Sketch. . leaves 13+ million shares that were sold by someone else (maybe FIL or AG ??). IPOs. . 2663916. ASX - By Stock. Share Interesting and positive early pre-clinical results. IMO the Starpharma HQ kool-aide would be tasting pretty bitter these days. 88. SPL Price at posting: 91. The total and absolute shame of this is that not once in their quarter of a century of existence have these "discussions" amounted to a deal. ASX - Day TradingI will just put it out there that I have been peeved off about our CEO Jackie Fairley and the performance of SPL for a while now. Altech Batteries (ASX:ATC) has confirmed its Silumina Anodes project can be eight times larger than previously thought. ASX - By Stock. Timeline. It is, to me, incredibly frustrating that SPL releases a good report with great promise and income mentions yet the market response is LIMP with a rise of. 1541401. And somebody must be buying all the shares that are being sold. SPL have hit road blocks with many of their products. 36. Click for more information. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. They not even have a license with SPL, just a basic research agreement. Charts. The Scripps in-vivo evidence using genetically engineered mice only became available to the November TGA conference at which such matters are. Share It is VERY disappointing that a CEO, Chair and company secretary can still throw a Sky and Land logo onto a corporate presentation as an indication of a partnership even though after 6. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial ReviewAbout this app. 6¢. SPL conducts a "trial" (use that word loosely) in of all places WA !! Yet our commercial hotshots cannot arrange a deal with a WA based company who appear highly capable and connected in getting distribution to sought after sectors like "Allied Health practitioners, the corporate sector and government". m. Last updated 15. ”For your information 55% of the company is held by institutions” ~ AB I. Share It would be silly to be tight on cash. Target our investor. 367026. Last updated 10. 0¢ Sentiment: Buy. ASX - General. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Your post is very vague in its relationship somehow with spl, but the intent of the constant negative narrative is obvious. ASX - By Stock. PEG-b-pHPMA-lactate: Docetaxel, microtubule inhibitor/hydrolytic linkerwaste of cash by the time spl manage to do anything with nasal spray covid will have a vaccine if there is one thing spl have deomstrated it is an inability to do anything in a timely fashion. Last updated 15. Latest Posts. ASX - General. Created with Sketch. Build your trading strategy and connect with. Share Interesting points John Some institutions might accept anything over $1. I sold out of my position in SPL at that time precisely because of this. I think this is the start of a trail that may lead somewhere in hopefully SPL offering shareholder clearer explainations and referenced articles / posters etc in announcements being on website and then later being unavaliable is a process across the ASX that has to be stopped. Charts. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. 5¢ Sentiment: Hold Disclosure: HeldThat's so funny col69 Antibotter post had you scrambling to find the link where he got that information then you copy paste the link and infer you knew already, if you did know you would for sure have posted this morning, some posters knew you were not one of them imo, still should have been an announcement let's hope results once collated. 38. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. I will be unable to listen to the AGM but look forward to listening to the audio and reading Hotcopper comments and feed back after my afternoon shift. Some have been mentioned on this thread previously. 50 or thereabouts. Its a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. Last updated 15. . 9¢. Change in substantial holding. ASX - By Stock. Created with Sketch. Last updated 15. 8¢. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is differentSPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Created with Sketch. ASX - By Stock. Again the trial results will be good but will they be sufficiently good to entice a Major into a deal. An expat Indonesian friend did have search for me but didn't find any promotion etc a little while ago. SPL wasn't exactly a penny dreadful while in the ASX 300 and they will have hurt with capital raising at three times the current price. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. 2. 10/10/23. Click for more information. 26. Talk with one of our capital market experts to learn more about our innovative and. Join the. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more.